Intuitive Surgical sees slower da Vinci procedure growth, expects 1% tariff hit to 2026 margins

Intuitive Surgical said quarterly revenue rose 19% year over year, beating analyst expectations, as adjusted earnings per share also topped consensus on higher procedure volumes and system placements.

The company said Q2 revenue was $2.89 billion, compared with a consensus estimate of $2.82 billion. Adjusted EPS was $2.80, versus expectations of $2.50. Adjusted net income was $1.00 billion, above the $897.85 million estimate.

The company repurchased 0.9 million shares for $380 million in Q2.

The current average analyst rating on the shares is buy, with 24 strong buy or buy, 10 hold, and 1 sell or strong sell ratings. The median 12-month price target is $558.00, about 43.5% above the July 15 closing price of $388.97.

The stock recently traded at 35 times next 12-month earnings, versus three months ago.